Medical Technology, Healthcare, Healthcare Technology, Bio-Tech
Location: Gaithersburg, MD
CEO: John Warden, Jr.
Hememics brings lab-quality test capabilities to the field at a lower cost, saving time and money while improving outcomes and user experience.
The Hememics platform features an affordable handheld reader and disposable plastic chips capable of performing tests on liquid samples (saliva, water, urine, and blood). It simultaneously detects small molecules and protein targets, under 5 minutes, at a fraction of the cost of traditional lab tests.
Hememics’ platform is able to address significant unmet needs across various industries due to outdated and inadequate diagnostic tools—many of which still rely on technology developed 40-50 years ago.
Interested in Investing?
Community Equity Partners works with accredited investors. We structure our investments through Special Purpose Vehicles (SPVs) for each company, prepare diligence reports and communicate company updates with our investor-members.
Please fill out the form to indicate your interest in investing in this company.